Kristen Hege, Member Board of Directors at KSQ Therapeutics, Inc., shared a post on LinkedIn:
“I am excited to announce I will be presenting at the upcoming Society for Immunotherapy of Cancer’s Spring Scientific – Next-gen Cell Therapies, T cell Engagers, and Combinations – in Tucson and Virtual on March 25–27.
I would like to personally invite you to register to attend for the in-person or virtual event…